Filed: 11/14/2025ACC: 0001420506-25-003321
📋 What this filing means
PARKMAN HEALTHCARE PARTNERS LLC filed this quarterly 13F‑HR report disclosing 91 equity positions with a total reported market value of $958.70M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
91
Positions
$958.70M
Total AUM (reported)
37.55M
Total Shares
Allocation by class
COM$715.63M74.6%
COM NEW$60.54M6.3%
UNIT SER 1$48.03M5.0%
SHS$35.14M3.7%
ORD SHS CL A$26.08M2.7%
COM SHS$22.35M2.3%
CL A$15.90M1.7%
Portfolio Concentration
Top 3$130.42M13.6%
4–10$186.30M19.4%
11–25$253.61M26.5%
Rest$388.37M40.5%
Top 3 weight
13.6%
Top 10 weight
33.0%
Voting Authority Distribution
Total shares with voting rights: 37.55M
Sole
Full voting authority
37.55M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole91
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings91
Rows:
INVESCO QQQ TR
SOLEShares80K
TypeSH
Market value$48.03M
5.01%
Sole
80K
Shared
0.00
None
0.00
BOSTON SCIENTIFIC CORP
SOLEShares434.38K
TypeSH
Market value$42.41M
4.42%
Sole
434.38K
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares87.69K
TypeSH
Market value$39.99M
4.17%
Sole
87.69K
Shared
0.00
None
0.00
INSULET CORP
SOLEShares116.24K
TypeSH
Market value$35.89M
3.74%
Sole
116.24K
Shared
0.00
None
0.00
CVS HEALTH CORP
SOLEShares379.49K
TypeSH
Market value$28.61M
2.98%
Sole
379.49K
Shared
0.00
None
0.00
KINIKSA PHARMACEUTICALS INTL
SOLEShares671.59K
TypeSH
Market value$26.08M
2.72%
Sole
671.59K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares1.15M
TypeSH
Market value$24.91M
2.60%
Sole
1.15M
Shared
0.00
None
0.00
ZIMMER BIOMET HOLDINGS INC
SOLEShares251.42K
TypeSH
Market value$24.76M
2.58%
Sole
251.42K
Shared
0.00
None
0.00
STRYKER CORPORATION
SOLEShares64.11K
TypeSH
Market value$23.70M
2.47%
Sole
64.11K
Shared
0.00
None
0.00
QIAGEN NV
SOLEShares500.16K
TypeSH
Market value$22.35M
2.33%
Sole
500.16K
Shared
0.00
None
0.00
MCKESSON CORP
SOLEShares28.54K
TypeSH
Market value$22.05M
2.30%
Sole
28.54K
Shared
0.00
None
0.00
DANAHER CORPORATION
SOLEShares110.54K
TypeSH
Market value$21.92M
2.29%
Sole
110.54K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares1.74M
TypeSH
Market value$21.13M
2.20%
Sole
1.74M
Shared
0.00
None
0.00
UNIQURE NV
SOLEShares345.36K
TypeSH
Market value$20.16M
2.10%
Sole
345.36K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares141.82K
TypeSH
Market value$19.91M
2.08%
Sole
141.82K
Shared
0.00
None
0.00
BIOGEN INC
SOLEShares130.16K
TypeSH
Market value$18.23M
1.90%
Sole
130.16K
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
SOLEShares455.52K
TypeSH
Market value$17.27M
1.80%
Sole
455.52K
Shared
0.00
None
0.00
UPSTREAM BIO INC
SOLEShares843.50K
TypeSH
Market value$15.87M
1.65%
Sole
843.50K
Shared
0.00
None
0.00
TENET HEALTHCARE CORP
SOLEShares74.33K
TypeSH
Market value$15.09M
1.57%
Sole
74.33K
Shared
0.00
None
0.00
XERIS BIOPHARMA HOLDINGS INC
SOLEShares1.79M
TypeSH
Market value$14.58M
1.52%
Sole
1.79M
Shared
0.00
None
0.00
LIVANOVA PLC
SOLEShares275.81K
TypeSH
Market value$14.45M
1.51%
Sole
275.81K
Shared
0.00
None
0.00
MBX BIOSCIENCES INC
SOLEShares773.30K
TypeSH
Market value$13.53M
1.41%
Sole
773.30K
Shared
0.00
None
0.00
AMICUS THERAPEUTICS INC
SOLEShares1.69M
TypeSH
Market value$13.30M
1.39%
Sole
1.69M
Shared
0.00
None
0.00
DOXIMITY INC
SOLEShares178.97K
TypeSH
Market value$13.09M
1.37%
Sole
178.97K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares846.90K
TypeSH
Market value$13.03M
1.36%
Sole
846.90K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
INVESCO QQQ TRSOLE | UNIT SER 1 | 80K | SH | $48.03M 5.01% | 80K | 0.00 | 0.00 |
BOSTON SCIENTIFIC CORPSOLE | COM | 434.38K | SH | $42.41M 4.42% | 434.38K | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 87.69K | SH | $39.99M 4.17% | 87.69K | 0.00 | 0.00 |
INSULET CORPSOLE | COM | 116.24K | SH | $35.89M 3.74% | 116.24K | 0.00 | 0.00 |
CVS HEALTH CORPSOLE | COM | 379.49K | SH | $28.61M 2.98% | 379.49K | 0.00 | 0.00 |
KINIKSA PHARMACEUTICALS INTLSOLE | ORD SHS CL A | 671.59K | SH | $26.08M 2.72% | 671.59K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 1.15M | SH | $24.91M 2.60% | 1.15M | 0.00 | 0.00 |
ZIMMER BIOMET HOLDINGS INCSOLE | COM | 251.42K | SH | $24.76M 2.58% | 251.42K | 0.00 | 0.00 |
STRYKER CORPORATIONSOLE | COM | 64.11K | SH | $23.70M 2.47% | 64.11K | 0.00 | 0.00 |
QIAGEN NVSOLE | COM SHS | 500.16K | SH | $22.35M 2.33% | 500.16K | 0.00 | 0.00 |
MCKESSON CORPSOLE | COM | 28.54K | SH | $22.05M 2.30% | 28.54K | 0.00 | 0.00 |
DANAHER CORPORATIONSOLE | COM | 110.54K | SH | $21.92M 2.29% | 110.54K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 1.74M | SH | $21.13M 2.20% | 1.74M | 0.00 | 0.00 |
UNIQURE NVSOLE | SHS | 345.36K | SH | $20.16M 2.10% | 345.36K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 141.82K | SH | $19.91M 2.08% | 141.82K | 0.00 | 0.00 |
BIOGEN INCSOLE | COM | 130.16K | SH | $18.23M 1.90% | 130.16K | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCSOLE | COM | 455.52K | SH | $17.27M 1.80% | 455.52K | 0.00 | 0.00 |
UPSTREAM BIO INCSOLE | COM | 843.50K | SH | $15.87M 1.65% | 843.50K | 0.00 | 0.00 |
TENET HEALTHCARE CORPSOLE | COM NEW | 74.33K | SH | $15.09M 1.57% | 74.33K | 0.00 | 0.00 |
XERIS BIOPHARMA HOLDINGS INCSOLE | COM | 1.79M | SH | $14.58M 1.52% | 1.79M | 0.00 | 0.00 |
LIVANOVA PLCSOLE | SHS | 275.81K | SH | $14.45M 1.51% | 275.81K | 0.00 | 0.00 |
MBX BIOSCIENCES INCSOLE | COM | 773.30K | SH | $13.53M 1.41% | 773.30K | 0.00 | 0.00 |
AMICUS THERAPEUTICS INCSOLE | COM | 1.69M | SH | $13.30M 1.39% | 1.69M | 0.00 | 0.00 |
DOXIMITY INCSOLE | CL A | 178.97K | SH | $13.09M 1.37% | 178.97K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 846.90K | SH | $13.03M 1.36% | 846.90K | 0.00 | 0.00 |
Page 1 of 4